Financial Ratios

UNICHEM LABORATORIES LTD.

NSE : UNICHEMLABBSE : 506690ISIN CODE : INE351A01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE496.0016.6 (+3.46 %)
PREV CLOSE ( ) 479.40
OPEN PRICE ( ) 494.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1119
TODAY'S LOW / HIGH ( )485.30 498.35
52 WK LOW / HIGH ( )271.65 579.8
NSE492.0510.15 (+2.11 %)
PREV CLOSE( ) 481.90
OPEN PRICE ( ) 495.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13054
TODAY'S LOW / HIGH( ) 489.00 499.00
52 WK LOW / HIGH ( )271.65 572
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-42.57-7.877.68-8.001.00
   CEPS(Rs)-27.523.9418.462.109.77
   DPS(Rs)0.004.004.004.004.00
   Book NAV/Share(Rs)336.94378.00382.01375.30387.60
   Tax Rate(%)-7.3936.1017.6111.75132.63
Margin Ratios
   Core EBITDA Margin(%)-8.66-4.628.49-10.02-6.28
   EBIT Margin(%)-25.15-8.985.96-6.91-2.17
   Pre Tax Margin(%)-26.02-9.205.84-7.06-2.23
   PAT Margin (%)-27.95-5.884.81-6.230.73
   Cash Profit Margin (%)-18.062.9411.561.637.10
Performance Ratios
   ROA(%)-9.98-1.781.76-1.860.23
   ROE(%)-11.91-2.072.03-2.100.26
   ROCE(%)-10.21-3.082.50-2.32-0.76
   Asset Turnover(x)0.360.300.370.300.32
   Sales/Fixed Asset(x)0.710.771.040.921.21
   Working Capital/Sales(x)1.190.891.200.780.61
Efficiency Ratios
   Fixed Capital/Sales(x)1.411.300.961.090.82
   Receivable days145.14143.48110.99132.06106.19
   Inventory Days160.11163.90113.93119.0090.89
   Payable days160.92194.36201.52235.09217.37
Valuation Parameters
   PER(x)0.000.0040.270.00194.50
   PCE(x)-10.5166.0416.7572.1319.92
   Price/Book(x)0.860.690.810.400.50
   Yield(%)0.001.541.292.642.06
   EV/Net Sales(x)1.851.971.890.971.22
   EV/Core EBITDA(x)-38.76-1251.8314.84102.2828.92
   EV/EBIT(x)-7.34-21.9731.67-14.00-56.22
   EV/CE(x)0.690.600.790.290.39
   M Cap / Sales1.901.941.941.181.42
Growth Ratio
   Net Sales Growth(%)13.73-16.1124.27-6.54-21.41
   Core EBITDA Growth(%)-3336.70-101.041568.75-78.99-98.76
   EBIT Growth(%)-218.53-226.48207.06-198.29-100.64
   PAT Growth(%)-440.69-202.49196.03-899.72-99.72
   EPS Growth(%)-440.69-202.49196.03-899.48-99.72
Financial Stability Ratios
   Total Debt/Equity(x)0.040.050.000.010.00
   Current Ratio(x)3.334.423.514.326.82
   Quick Ratio(x)2.092.932.473.415.81
   Interest Cover(x)-28.75-40.8251.47-48.78-33.97
   Total Debt/Mcap(x)0.050.070.000.010.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.